SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 15, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

The selling is modest in absolute terms and negligible relative to market cap. These appear to be routine, pre-planned transactions following stock option exercises rather than a signal of fundamental concern. Traders should monitor for any changes in forward-looking statements or corporate guidance, but no immediate reaction is warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$574.96
T+0 close · Apr 14, 2026 · via day close
Latest settled
−3.91%
T+60 · $552.48
Vs SPY
−11.31%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $574.96entry
  2. T+1 · 7mo ago +0.41%α +0.16% · $577.33
  3. T+5 · 7mo ago −0.15%α −1.79% · $574.11
  4. T+20 · 6mo ago +1.18%α −4.86% · $581.74
  5. T+60 · 4mo ago −3.91%α −11.31% · $552.48
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three United Therapeutics executives, including the CEO, CFO, and General Counsel, conducted open-market share sales totaling $459K over a 7-day period, following large non-cash derivative exercises. The sales represent less than 0.002% of the company's $25.4B market cap and appear to be part of pre-planned transactions following stock option exercises.

Key Financial Metrics

Direction
selling
Total Value
$459.0K
Insiders
3

Key Facts

  • CEO Martine Rothblatt sold $227K worth of shares (395 shares) across multiple days in the cluster window at prices between $569.78 and $575.29.
  • CFO James Edgemond sold $298K worth of shares (520 shares) on April 16, following the exercise of 20,000 derivative securities at two different strike prices.
  • EVP Paul Mahon sold $115K worth of shares (200 shares) on April 16, following the exercise of 16,600 derivative securities.
  • Total open-market sales in the cluster: $459K, representing less than 0.002% of $25.4B market cap.
  • Multiple non-cash derivative exercises occurred at $0 and at strike prices ($135.42, $146.03), indicating pre-scheduled option expirations or vesting events.

Financial Impact

$459,000 in open-market sales

insider ownershipshare count

Risk Factors

  • Perception risk: Concentrated selling by top executives could be misinterpreted as lack of confidence, despite likely being mechanical.
  • Execution risk: Future larger-scale sales could occur if more options are exercised and sold under Rule 10b5-1 plans.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1776459415868

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026